RheumaTrace

EUIPO EUIPO 2023 Application under examination

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark RheumaTrace was filed as Word mark on 08/14/2023 at the European Union Intellectual Property Office. The current status of the mark is "Application under examination".

Trademark Details Last update: March 29, 2024

Trademark form Word mark
File reference 018913624
Application date August 14, 2023

Trademark owner

Herlev Hovedgade 205
2730 Herlev
DK

Trademark representatives

Langebrogade 3B 1411 København K DK

goods and services

5 Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; Biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; Diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; Diagnostic preparations, substances and materials; Medical diagnostic test strips; Diagnostic preparations for medical purposes; Diagnostic agents for medical use
42 Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; Design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; Design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; Scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; Laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; Advice, information and assistance relating to the foregoing

Trademark history

Date Document number Area Entry
September 11, 2023 Transfer / Change of address, Registered

ID: 11018913624